Published in Am J Manag Care on November 01, 2008
Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect (2013) 1.38
Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis (2011) 1.17
Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data. Int J Bipolar Disord (2013) 0.88
Medication treatment complexity and adherence in children with CKD. Clin J Am Soc Nephrol (2013) 0.84
Concern still warranted: medication burden and persistence with lipid-lowering drugs. Am J Manag Care (2009) 0.75
Managing dyslipidemia in primary care with restricted access to lipid-modifying therapy. Am Health Drug Benefits (2010) 0.75
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther (2006) 2.86
Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm (2008) 2.55
Incident depression increases medical utilization in Medicaid patients with hypertension. Expert Rev Cardiovasc Ther (2014) 1.96
Burden of concomitant asthma and COPD in a Medicaid population. Chest (2008) 1.87
School-based obesity interventions: a literature review. J Sch Health (2008) 1.55
Disparities among older adults in measures of cognitive function by race or ethnicity. J Gerontol B Psychol Sci Soc Sci (2005) 1.43
Pharmacotherapy after myocardial infarction: disease management versus usual care. Am J Manag Care (2008) 1.40
Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res (2007) 1.16
Health information technology--results from a roundtable discussion. J Manag Care Pharm (2009) 1.16
Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Med Care Res Rev (2006) 1.13
Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One (2011) 1.12
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin (2010) 1.12
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med (2009) 1.09
The impact of health literacy on cardiovascular disease. Vasc Health Risk Manag (2006) 1.05
Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth. PLoS One (2013) 1.02
Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling. J Pineal Res (2012) 1.01
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy (2005) 0.99
Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One (2012) 0.97
Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma (2012) 0.95
Discontinuation rates of topical glaucoma medications in a managed care population. Am J Manag Care (2002) 0.95
The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens (Greenwich) (2011) 0.93
TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway. Cancer Prev Res (Phila) (2013) 0.91
Readmissions after unauthorized discharges in the cardiovascular setting. Med Care (2011) 0.90
Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis. J Manag Care Pharm (2014) 0.89
Failure to fill electronically prescribed antidepressant medications: a retrospective study. Prim Care Companion CNS Disord (2011) 0.86
Medicare Part D-a roundtable discussion of current issues and trends. J Manag Care Pharm (2009) 0.85
A retrospective review of the effect of COX-2 inhibitors on blood pressure change. Am J Ther (2003) 0.85
Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath (2013) 0.84
Delivering cost-effective care for COPD in the USA: recent progress and current challenges. Expert Rev Pharmacoecon Outcomes Res (2012) 0.84
Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid. J Natl Med Assoc (2004) 0.83
REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci (2008) 0.83
The cost effectiveness and budget impact of natalizumab for formulary inclusion. J Med Econ (2010) 0.83
New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. Ann Pharmacother (2007) 0.82
Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin. J Manag Care Spec Pharm (2014) 0.82
You wrote the prescription, but will it get filled? J Fam Pract (2011) 0.81
Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells. Biochem Biophys Res Commun (2010) 0.80
Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease. Ethn Dis (2009) 0.79
A qualitative evaluation of a citywide Community Health Partnership program. J Natl Med Assoc (2012) 0.78
Multispecialist Care and Mortality in Hepatocellular Carcinoma. Am J Clin Oncol (2015) 0.78
A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders. J Manag Care Spec Pharm (2015) 0.78
Association between mental health and comorbid obesity and hypertension among children and adolescents in the US. Eur Child Adolesc Psychiatry (2014) 0.77
A novel monoclonal antibody identified hepatic stem-like cells in rats. Med Mol Morphol (2011) 0.77
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival. Value Health (2013) 0.77
Sexual dimorphism in LEC rat liver: suppression of carbonic anhydrase III by copper accumulation during hepatocarcinogenesis. Biomed Res (2011) 0.77
The future of Medicare Part D drug plans--results from a roundtable discussion. J Manag Care Pharm (2009) 0.77
Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. Am J Manag Care (2010) 0.77
Disease-modifying therapy and hospitalization risk in heart failure patients. Am J Manag Care (2015) 0.76
Responses of Azorhizobium caulinodans to cadmium stress. FEMS Microbiol Ecol (2005) 0.76
Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk. Cancer Med (2014) 0.76
Developing benchmarks for adherence studies. Expert Rev Pharmacoecon Outcomes Res (2005) 0.76
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. Mol Cancer (2014) 0.76
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram. Clin Ther (2006) 0.75
Summary quality scores for pharmacoeconomic studies: balancing validity with need. J Manag Care Pharm (2003) 0.75
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiol Res Pract (2009) 0.75
Medication Management and e-Care Planning: What are the Opportunities for the Future? J Gerontol Nurs (2015) 0.75
Cost studies in clinical trials. Expert Rev Pharmacoecon Outcomes Res (2004) 0.75
Case for a pharmacy-centered medical home. Expert Rev Pharmacoecon Outcomes Res (2009) 0.75
Research to real-world application: experts weigh in on the underuse of anticoagulants. Am J Manag Care (2014) 0.75
Navigating Medicare Part D Websites: Are the Part D Plans in Compliance? J Gerontol Nurs (2016) 0.75
Clinical evaluation of natalizumab for formulary consideration. Expert Opin Biol Ther (2010) 0.75
Impact of the fourth hurdle on the international pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res (2003) 0.75
Diabetes control through an educational intervention. Ethn Dis (2014) 0.75
Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients. Med Care (2017) 0.75
Effect of initial ziprasidone dose on treatment persistence in schizophrenia. Schizophr Res (2006) 0.75
Pharmacy measures to improve medication use through health-literacy principles. Manag Care Interface (2007) 0.75
Prescribing trends and drug budget impact of the ARBs in the UK. Value Health (2008) 0.75
Formulary decision methodology in the context of health system costs and insurance trends. Expert Rev Pharmacoecon Outcomes Res (2004) 0.75
Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. Expert Rev Clin Pharmacol (2014) 0.75
Health care cost of analgesic use in hypertensive patients. Clin Ther (2004) 0.75
Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C. Expert Rev Gastroenterol Hepatol (2014) 0.75
Aspirin use in elderly women receiving medication therapy management services. Adv Ther (2010) 0.75